High HAA intake was associated with an increased risk of prostate cancer among each genotype and NAT-imputed phenotype, with the exception of the CYP1A2 CC genotype (OR, 2.65; 95% CI, 0.97–7.29; P for interaction, 0.003). The gene discussed is CYP1A2; the disease is Familial prostate cancer.